Literature DB >> 14687010

Physiotherapy for tension-type headache: a controlled study.

P Torelli1, R Jensen, J Olesen.   

Abstract

The role of non-pharmacological therapies in the preventive treatment of tension-type headache (TTH) is still an object of debate. The primary aim of this study was therefore to investigate the therapeutic effect of physiotherapy in properly classified patients with TTH in a controlled trial. Fifty patients with TTH, 26 with episodic, frequent (ETTH) and 24 with chronic TTH (CTTH) fulfilling the International Headache Society classification criteria were included in the study. After a 4-week run-in period, they were randomized to either an 8-week period of standardized physiotherapy (group 1) or to an 8-week observation period followed by an identical course of physiotherapy (group 2); after the physiotherapy all patients were followed for a 12-week follow-up period. We then evaluated the number of days with headache, severity and duration of the headache attacks, and drug consumption for symptomatic treatment before and after the course of physiotherapy. Forty-eight patients completed the study. The average number of days with headache per 4-week period was reduced from 16.3 days at baseline to 12.3 days in the last 4 weeks of treatment [from 14.5 days to 10.5 days (P < 0.001) in group 1 and from 18.1 days to 14.1 days (P < 0.001) in group 2]. Severity and duration of headache as well as drug consumption were unchanged throughout the study. Analysing the response to treatment separately in the various subgroups, we found that the number of responders was significantly higher among patients with CTTH vs. patients with ETTH (P < 0.002) and in females vs. males (P < 0.02). No differences were found between patients with and without disorder of pericranial muscles. We conclude that a standardized physiotherapy programme has a good therapeutic effect, albeit on a restricted group of patients.

Entities:  

Mesh:

Year:  2004        PMID: 14687010     DOI: 10.1111/j.1468-2982.2004.00633.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  25 in total

Review 1.  Alternative therapies for tension-type headache.

Authors:  Marc E Lenaerts
Journal:  Curr Pain Headache Rep       Date:  2004-12

Review 2.  Does exercise therapy improve headache? a systematic review with meta-analysis.

Authors:  James Fricton; Ana Velly; Wei Ouyang; John O Look
Journal:  Curr Pain Headache Rep       Date:  2009-12

3.  Drug and Nondrug Treatment in Tension-type Headache.

Authors:  Lars Bendtsen
Journal:  Ther Adv Neurol Disord       Date:  2009-05       Impact factor: 6.570

4.  Efficacy of manual and manipulative therapy in the perception of pain and cervical motion in patients with tension-type headache: a randomized, controlled clinical trial.

Authors:  Gemma V Espí-López; Antonia Gómez-Conesa
Journal:  J Chiropr Med       Date:  2014-03

Review 5.  Tension-type headache in children and adolescents.

Authors:  Pirjo Anttila
Journal:  Curr Pain Headache Rep       Date:  2004-12

Review 6.  [A chronic problem-the chronic headache patient].

Authors:  A Straube
Journal:  Schmerz       Date:  2004-10       Impact factor: 1.107

7.  Tension-type Headache in the Elderly.

Authors:  Robert G Kaniecki
Journal:  Curr Treat Options Neurol       Date:  2007-01       Impact factor: 3.598

Review 8.  Does exercise make migraines worse and tension type headaches better?

Authors:  Nada Ahmad Hindiyeh; John Claude Krusz; Robert Paul Cowan
Journal:  Curr Pain Headache Rep       Date:  2013-12

Review 9.  Complementary and alternative approaches to the treatment of tension-type headache.

Authors:  Christina Sun-Edelstein; Alexander Mauskop
Journal:  Curr Pain Headache Rep       Date:  2012-12

Review 10.  [Therapy of primary chronic headache: chronic migraine, chronic tension type headache and other forms of daily chronic headache].

Authors:  A Straube; A May; P Kropp; Z Katsarava; G Haag; C Lampl; P S Sándor; H-C Diener; S Evers
Journal:  Schmerz       Date:  2008-10       Impact factor: 1.107

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.